| Product Type | Impurity Standards |
| CAT. No. | MRL-P56002 |
| CAS. No. | NA |
| Mol. Formula | C13H11ClN6O |
| Mol. Weight | 302.72 |
| Synonyms | NA |
| Chemical Name | N-(2-Chloropyrimidin-4-yl)-N-(2,3-dimethyl-2H-indazol-6-yl)nitrous amide |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | Please Enquire |
Nitrosamines can be formed through various chemical processes, including the reaction between nitrites and secondary amines in certain conditions. It is a N-Nitroso of secondary amine present in Pazopanib. Nitrosamines are part of a broader class of compounds known as N-nitroso compounds. Pazopanib is a tyrosine kinase inhibitor used in the treatment of certain types of cancer, particularly advanced renal cell carcinoma (kidney cancer) and soft tissue sarcoma. As a targeted therapy, pazopanib interferes with the signaling pathways involved in the growth and spread of cancer cells by inhibiting specific tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived growth factor receptor (PDGFR), and c-kit. By blocking these pathways, pazopanib helps impede angiogenesis (the formation of new blood vessels) and suppresses the tumors ability to grow and metastasize. It is administered orally and is part of a broader treatment strategy for individuals with specific types of advanced or metastatic cancers. Buy high quality N-Nitroso Pazopanib Impurity from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporter of N-Nitroso Pazopanib Impurity.